DK200586D0 - Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler - Google Patents

Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler

Info

Publication number
DK200586D0
DK200586D0 DK200586A DK200586A DK200586D0 DK 200586 D0 DK200586 D0 DK 200586D0 DK 200586 A DK200586 A DK 200586A DK 200586 A DK200586 A DK 200586A DK 200586 D0 DK200586 D0 DK 200586D0
Authority
DK
Denmark
Prior art keywords
antithromobotic
application
effect
medicinal products
pyridinone compounds
Prior art date
Application number
DK200586A
Other languages
English (en)
Other versions
DK200586A (da
Inventor
Juergen Daemmgen
Helmut Ballhause
Walter Haarman
Joachim Heider
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK200586D0 publication Critical patent/DK200586D0/da
Publication of DK200586A publication Critical patent/DK200586A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK200586A 1985-05-03 1986-05-01 Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler DK200586A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3515882 1985-05-03
DE19853515882 DE3515882A1 (de) 1985-05-03 1985-05-03 Arzneimittel, enthaltend pyridinone mit antithrombotischen wirkungen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
DK200586D0 true DK200586D0 (da) 1986-05-01
DK200586A DK200586A (da) 1986-11-04

Family

ID=6269707

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200586A DK200586A (da) 1985-05-03 1986-05-01 Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler

Country Status (6)

Country Link
EP (1) EP0210342A2 (da)
JP (1) JPS61254524A (da)
AU (1) AU5706486A (da)
DE (1) DE3515882A1 (da)
DK (1) DK200586A (da)
ZA (1) ZA863304B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3533542B2 (ja) * 1994-03-08 2004-05-31 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
RU2177317C1 (ru) * 2000-10-24 2001-12-27 Московский научно-исследовательский институт медицинской экологии (МНИИМЭ) Производные хинолина для коррекции системы гемостаза, фармацевтическая композиция, средство для коррекции гемостаза
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
CA2584485C (en) 2004-10-20 2013-12-31 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
DK2118074T3 (da) 2007-02-01 2014-03-10 Resverlogix Corp Forbindelser til forebyggelse og behandling af hjertekarsygdomme
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
NZ594332A (en) 2009-01-08 2013-09-27 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular disease
KR101709492B1 (ko) 2009-03-18 2017-02-23 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Also Published As

Publication number Publication date
EP0210342A2 (de) 1987-02-04
ZA863304B (en) 1988-01-27
AU5706486A (en) 1986-11-06
DK200586A (da) 1986-11-04
DE3515882A1 (de) 1986-11-06
JPS61254524A (ja) 1986-11-12

Similar Documents

Publication Publication Date Title
DK153787D0 (da) Laegemidler med langsom frigivelse
BR8601675A (pt) Fralda descartavel
SE8600668D0 (sv) 4-substituted androstendione derivatives and process for their preparation
DK625087A (da) Heteroaromatiske aminoderivater dsamt laegemidler med indhold af saadanne forbindelser
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
DK404487D0 (da) Praeparat med helende virkning paa epitelsaar
KR870700618A (ko) 크로모글릭산유도체와 그 제조방법 및 약학적 조성물
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
PH22478A (en) Substituted alkyl pyridinium or pyridimium salts and pharmaceutical preparation thereof
DK599986A (da) Terapeutisk middel i form af et hudplaster
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
IT1191639B (it) Composizione farmaceutica contenente fosfocreatina e metodo per preparla
DK79986A (da) Pyridinderivater
DK201884D0 (da) Farmaceutisk praeparat med anti-hypertensiv virkning
DK560989A (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
DK41585D0 (da) Udtrykkelse af human alfa-1-antitrypsin i gaer
DK100586A (da) Plaster til vedvarende frigoerelse af laegemidler
FI864092A7 (fi) Bruksvagn foersedd med frigoerningsanordning
DK499986A (da) Farmaceutisk praeparat med antibakteriel virkning
DK453785A (da) Laegemiddel med grf-virkning
DK152887C (da) Liggemoebel for to personer
RO91711A2 (ro) Produs medicamentos reconfortant
BR6500407U (pt) Composicao medicinal
FI921215A7 (fi) Epipodofyllotoksiinin ja sitä lähellä olevien yhdisteiden valmistuksessa käyttökelpoisia välituotteita ja menetelmiä niiden valmistamiseksi
DK295986A (da) Engangsble

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment